SCHEMBL7435867

SCHEMBL7435867

CC[C@H](N)c1ccc2ccccc2c1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
UGT2B7 P16662 1/20 0.52
SLC6A4 P31645 10/20 0.49
SLC6A2 P23975 9/20 0.49
SLC6A3 Q01959 9/20 0.49
CYP2D6 P10635 6/20 0.49
KCNH2 Q12809 6/20 0.49
CYP3A4 P08684 5/20 0.49
AOC3 Q16853 2/20 0.49
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
HTR2B P41595 1/20 0.47
CYP1A2 P05177 2/20 0.45
CYP2A6 P11509 1/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
TSHR P16473 1/20 0.45
HIF1A Q16665 1/20 0.45
ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6008493 1.00 UGT2B7 (0.52) UGT2B7SLC6A4SLC6A2SLC6A3CYP2D6
SCHEMBL7436041 1.00 UGT2B7 (0.52) UGT2B7SLC6A4SLC6A2SLC6A3CYP2D6
SCHEMBL11624148 0.85 UGT2B7 (0.48) UGT2B7SLC6A4SLC6A2SLC6A3CYP2D6
SCHEMBL15345330 0.82 SLC2A1 (0.46) UGT2B7SLC6A4SLC6A2SLC6A3CYP2D6
SCHEMBL31036013 0.82 SLC2A1 (0.46) UGT2B7SLC6A4SLC6A2SLC6A3CYP2D6
SCHEMBL11631139 0.82 SLC6A2 (0.54) UGT2B7SLC6A4SLC6A2SLC6A3CYP2D6
Hydrochloric Acid SCHEMBL28703571 0.80 SLC6A2 (0.56) UGT2B7SLC6A4SLC6A2SLC6A3CYP2D6
SCHEMBL1661660 0.80 UGT2B7 (0.52) UGT2B7SLC6A4SLC6A2SLC6A3CYP2D6
SCHEMBL4335674 0.80 UGT2B7 (0.52) UGT2B7SLC6A4SLC6A2SLC6A3CYP2D6
SCHEMBL29463570 0.80 UGT2B7 (0.52) UGT2B7SLC6A4SLC6A2SLC6A3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187905-B1 PEPTIDE COMPOUND WHICH INHIBITS VIRAL PROTEINASES; VIRICIDES FOR HEPATITIS C, HEPATITIS G, AND HUMAN GB VIRUSES HOFFMANN-LA ROCHE INC. 2001-02-13 US disclosed